Twice-a-day Crixivan study discontinued.
D019380:Anti-HIV Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage*
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir